agilon health, inc. (NYSE:AGL) Given Average Recommendation of “Reduce” by Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been assigned an average rating of “Reduce” from the twenty-one ratings firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $4.28.

Several equities research analysts have commented on AGL shares. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Barclays dropped their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Sanford C. Bernstein started coverage on shares of agilon health in a research note on Wednesday, December 11th. They set a “market perform” rating and a $2.50 target price on the stock. Finally, Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th.

agilon health Price Performance

NYSE AGL opened at $1.91 on Wednesday. The stock’s fifty day moving average price is $2.29 and its 200 day moving average price is $4.19. agilon health has a 1 year low of $1.50 and a 1 year high of $13.28. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market cap of $786.95 million, a price-to-earnings ratio of -2.03 and a beta of 0.51.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the firm earned ($0.06) EPS. As a group, equities research analysts forecast that agilon health will post -0.52 earnings per share for the current year.

Insider Activity

In other news, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was acquired at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock worth $198,100 over the last ninety days. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of agilon health during the 3rd quarter worth about $28,000. City State Bank acquired a new stake in shares of agilon health during the third quarter valued at about $52,000. Allspring Global Investments Holdings LLC raised its stake in shares of agilon health by 17,790.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after acquiring an additional 10,674 shares during the period. Signaturefd LLC lifted its holdings in shares of agilon health by 166.2% in the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after acquiring an additional 7,398 shares during the last quarter. Finally, CIBC Asset Management Inc acquired a new position in shares of agilon health in the 2nd quarter worth approximately $78,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.